Publication | Closed Access

6568 POSTER Phase II trial of the novel epothilone ZK-EPO as second-line therapy in patients with stage IIIB or stage IV non-small-cell lung cancer

OncologyMedicineNovel Epothilone Zk-epoMetronomic TherapyBronchial NeoplasmStage IiibCancer TreatmentSecond-line TherapyPharmacologyRadiation OncologyLung CancerCancer Research